Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Drug Metabolism Reviews | journal | 0.984 Q1 | 108 | 29 | 84 | 4108 | 566 | 84 | 7.10 | 141.66 | 39.02 | |
52 | Expert Opinion on Emerging Drugs | journal | 0.972 Q1 | 54 | 34 | 91 | 3255 | 366 | 86 | 3.53 | 95.74 | 36.04 | |
53 | Investigational New Drugs | journal | 0.965 Q1 | 97 | 181 | 455 | 5921 | 1832 | 454 | 3.98 | 32.71 | 33.43 | |
54 | Infection and Drug Resistance | journal | 0.944 Q1 | 65 | 542 | 1115 | 21858 | 5304 | 1098 | 4.33 | 40.33 | 42.36 | |
55 | Pharmacopsychiatry | journal | 0.942 Q1 | 84 | 33 | 103 | 1731 | 396 | 86 | 1.91 | 52.45 | 44.06 | |
56 | HIV Medicine | journal | 0.936 Q1 | 86 | 112 | 321 | 3718 | 828 | 276 | 2.63 | 33.20 | 50.40 | |
57 | OpenNano | journal | 0.932 Q1 | 21 | 2 | 12 | 106 | 151 | 12 | 10.00 | 53.00 | 50.00 | |
58 | Expert Review of Clinical Pharmacology | journal | 0.927 Q1 | 60 | 135 | 357 | 10829 | 1505 | 314 | 3.68 | 80.21 | 44.22 | |
59 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 0.923 Q1 | 47 | 56 | 170 | 4075 | 737 | 168 | 4.35 | 72.77 | 39.25 | |
60 | Cannabis and Cannabinoid Research | journal | 0.917 Q1 | 42 | 58 | 103 | 2740 | 652 | 97 | 4.63 | 47.24 | 43.53 | |
61 | Vascular Health and Risk Management | journal | 0.902 Q1 | 82 | 78 | 153 | 3796 | 677 | 153 | 4.49 | 48.67 | 33.68 | |
62 | Journal of Cardiovascular Development and Disease | journal | 0.897 Q1 | 32 | 188 | 159 | 10975 | 621 | 153 | 4.21 | 58.38 | 37.60 | |
63 | Breast Cancer | journal | 0.883 Q1 | 66 | 142 | 326 | 4798 | 1313 | 314 | 3.12 | 33.79 | 43.00 | |
64 | Expert Opinion on Drug Safety | journal | 0.882 Q1 | 90 | 143 | 402 | 10125 | 1584 | 369 | 3.78 | 70.80 | 43.21 | |
65 | Pharmacoepidemiology and Drug Safety | journal | 0.868 Q2 | 109 | 184 | 597 | 6052 | 1500 | 552 | 2.41 | 32.89 | 52.95 | |
66 | Contemporary Clinical Trials | journal | 0.867 Q2 | 75 | 291 | 573 | 14278 | 1295 | 564 | 2.07 | 49.07 | 55.27 | |
67 | Trials | journal | 0.865 Q2 | 98 | 924 | 2484 | 34482 | 6432 | 2410 | 2.46 | 37.32 | 47.45 | |
68 | Infection and Chemotherapy | journal | 0.863 Q2 | 38 | 88 | 165 | 2566 | 619 | 151 | 4.06 | 29.16 | 45.71 | |
69 | Advances in Pharmacological Sciences | journal | 0.862 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
70 | Cardiovascular Drugs and Therapy | journal | 0.860 Q2 | 79 | 114 | 242 | 6200 | 911 | 210 | 3.60 | 54.39 | 34.07 | |
71 | Experimental and Clinical Psychopharmacology | journal | 0.856 Q2 | 101 | 137 | 203 | 8607 | 603 | 200 | 3.12 | 62.82 | 55.75 | |
72 | Expert Review of Anticancer Therapy | journal | 0.852 Q2 | 85 | 127 | 346 | 9854 | 1422 | 302 | 3.25 | 77.59 | 46.44 | |
73 | Cancer Chemotherapy and Pharmacology | journal | 0.848 Q2 | 122 | 174 | 680 | 6355 | 2399 | 669 | 3.31 | 36.52 | 34.82 | |
74 | Therapeutic Advances in Drug Safety | journal | 0.837 Q2 | 46 | 35 | 123 | 1607 | 454 | 102 | 2.87 | 45.91 | 44.02 | |
75 | Antiviral Therapy | journal | 0.835 Q2 | 93 | 46 | 182 | 879 | 437 | 174 | 1.65 | 19.11 | 52.26 | |
76 | Clinical Psychopharmacology and Neuroscience | journal | 0.835 Q2 | 42 | 84 | 219 | 4010 | 677 | 209 | 3.09 | 47.74 | 36.17 | |
77 | Biologics: Targets and Therapy | journal | 0.832 Q2 | 47 | 40 | 48 | 2810 | 221 | 48 | 5.24 | 70.25 | 45.45 | |
78 | AIDS Research and Therapy | journal | 0.827 Q2 | 49 | 99 | 134 | 3589 | 377 | 134 | 2.84 | 36.25 | 41.32 | |
79 | Clinical Therapeutics | journal | 0.824 Q2 | 150 | 221 | 671 | 9084 | 1978 | 590 | 2.90 | 41.10 | 43.65 | |
80 | Therapeutic Advances in Cardiovascular Disease | journal | 0.816 Q2 | 41 | 10 | 75 | 428 | 201 | 66 | 3.11 | 42.80 | 17.14 | |
81 | CPT: Pharmacometrics and Systems Pharmacology | journal | 0.814 Q2 | 55 | 139 | 261 | 4673 | 943 | 240 | 3.82 | 33.62 | 36.82 | |
82 | OncoTargets and Therapy | journal | 0.811 Q2 | 86 | 454 | 3005 | 19216 | 12801 | 3000 | 4.25 | 42.33 | 41.28 | |
83 | World Journal of Men?s Health | journal | 0.788 Q2 | 29 | 44 | 161 | 2257 | 672 | 149 | 4.17 | 51.30 | 27.80 | |
84 | Antibiotics | journal | 0.785 Q2 | 77 | 1553 | 1305 | 93008 | 6858 | 1277 | 5.08 | 59.89 | 47.93 | |
85 | Open Access Journal of Clinical Trials | journal | 0.785 Q2 | 15 | 6 | 17 | 202 | 16 | 17 | 1.17 | 33.67 | 52.94 | |
86 | Pharmaceutical Statistics | journal | 0.775 Q2 | 46 | 94 | 198 | 2696 | 247 | 184 | 1.01 | 28.68 | 27.70 | |
87 | Inflammopharmacology | journal | 0.772 Q2 | 68 | 138 | 366 | 8645 | 1721 | 360 | 4.66 | 62.64 | 44.32 | |
88 | Annals of Pharmacotherapy | journal | 0.756 Q2 | 122 | 178 | 504 | 5814 | 1352 | 389 | 2.69 | 32.66 | 48.89 | |
89 | Chemotherapy | journal | 0.742 Q2 | 61 | 39 | 98 | 1209 | 286 | 95 | 3.06 | 31.00 | 38.20 | |
90 | Expert Opinion on Pharmacotherapy | journal | 0.735 Q2 | 93 | 236 | 670 | 18660 | 2242 | 576 | 3.44 | 79.07 | 38.19 | |
91 | European Journal of Clinical Pharmacology | journal | 0.732 Q2 | 123 | 211 | 607 | 6867 | 1647 | 511 | 2.68 | 32.55 | 44.36 | |
92 | Cardiovascular Therapeutics | journal | 0.725 Q2 | 54 | 37 | 150 | 1540 | 510 | 149 | 3.36 | 41.62 | 44.91 | |
93 | Clinical Drug Investigation | journal | 0.718 Q2 | 67 | 108 | 364 | 3657 | 1097 | 334 | 3.05 | 33.86 | 39.69 | |
94 | Paediatric Drugs | journal | 0.709 Q2 | 70 | 49 | 153 | 3421 | 591 | 147 | 4.17 | 69.82 | 48.57 | |
95 | PPAR Research | journal | 0.703 Q2 | 59 | 25 | 62 | 1408 | 233 | 62 | 3.93 | 56.32 | 43.94 | |
96 | Journal of Aerosol Medicine and Pulmonary Drug Delivery | journal | 0.699 Q2 | 81 | 40 | 121 | 1598 | 424 | 112 | 3.78 | 39.95 | 40.85 | |
97 | Reading Teacher | journal | 0.689 Q2 | 60 | 91 | 293 | 2666 | 371 | 245 | 1.18 | 29.30 | 83.51 | |
98 | Journal of Clinical Pharmacology | journal | 0.687 Q2 | 130 | 200 | 550 | 7850 | 1658 | 513 | 2.83 | 39.25 | 41.41 | |
99 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.685 Q2 | 57 | 73 | 187 | 4001 | 505 | 179 | 2.51 | 54.81 | 32.88 | |
100 | Journal of Biopharmaceutical Statistics | journal | 0.679 Q2 | 56 | 58 | 249 | 1352 | 276 | 237 | 1.12 | 23.31 | 38.62 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®